Recombinant Human IL-36 gamma/IL-1F9 Protein Summary
Product Specifications
Met1-Asp169
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
2320-IL
Formulation | Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and TCEP with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
2320-IL/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in Tris, NaCl and TCEP. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: IL-36 gamma/IL-1F9
Human interleukin 36 gamma (IL‑36 gamma ; formerly known as IL‑1F9, IL‑1 epsilon (epsilon) and IL‑1H1) is a secreted member of the IL‑1 family of proteins (1‑5). It currently is one of at least four IL‑1 family members that have been renamed, the others being IL‑36 alpha (formerly IL‑1F6), IL‑36 beta (formerly IL‑1F8) IL‑37 (formerly IL‑1F7) and IL‑36ra (formerly IL‑1F5) (1). All family members show a 12 beta ‑strand, beta ‑trefoil configuration, and all family members are believed to have arisen from a common ancestral gene that has undergone multiple duplications (6). IL‑36 gamma is synthesized as a 19 kDa, 169 amino acid (aa) protein that contains no signal sequence, no prosegment and no potential N‑linked glycosylation site(s) (3, 4, 7). The molecule is secreted via a nonclassical pathway and likely requires the presence of extracellular ATP (7, 8). Human to mouse, IL‑36 gamma shares 53% aa identity. Within the family, IL‑36 gamma shares 30% aa identity with IL‑1ra, and 23%, 33%, 57%, 35%, 45% and 32% aa identity with IL‑1 beta, IL‑36ra, IL‑36 alpha, IL‑37, IL‑36 beta and IL‑1F10, respectively. Cells reported to express IL‑36 gamma include Langerhans cells, keratinocytes, monocytes, bronchial epithelium plus Chief cells and Parietal cells of the stomach (6 ‑ 10). The receptor for IL‑36 alpha is reported to be a combination of IL‑1Rrp2 and IL‑1 RAcP (9). Recombinant IL‑136 gamma, along with IL‑36 alpha and IL‑36 beta, has been shown to act as an agonist by activating the pathway involving NF‑ kappa B and MAPK in an IL‑1Rrp2 dependent manner. This suggests that IL‑36 gamma may signal in similar fashion to IL‑1 and IL‑18 by having a binding receptor which, upon ligation, recruits a second receptor as a signaling component, forming an active heterodimeric receptor complex. Activities attributed to IL‑36 gamma include a down‑regulation of betacellulin, an up‑regulation of MMP‑9 and ‑10, and the activation of both macrophages and fibroblasts, resulting in the release of multiple chemokines such as CXCL1, 2, 3 and 8, plus CCL2, 3 and 20 (9 ‑ 11).
- Dinarello, C. et al. (2010) Nat. Immunol. 11:973.
- barksby, H.E. et al. (2007) Clin. Exp. Immunol. 149:217.
- Smith, D. E. et al. (2000) J. Biol. Chem. 275 :1169.
- Kumar, S. et al. (2000) J. Biol. Chem. 275 :10308.
- Nicklin, M.J.H. et al. (2002) Genomics. 79:718.
- Dunn, E. et al. (2001) Trends Immunol. 22:533.
- Debets, R. et al. (2001) J. Immunol. 167:1440.
- Johnston, A. et al. (2011) J. Immunol. 186:2613.
- Chustz, R.T. et al. (2010) Am. J. Respir. Cell Mol. Biol. [Epub ahead of print].
- Ramadas, R.A. et al. (2011) Am. J. Respir. Cell Mol. Biol. 44:134.
- Towne, J.E. et al. (2004) J. Biol. Chem. 279:13677.
Citations for Recombinant Human IL-36 gamma/IL-1F9 Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
6
Citations: Showing 1 - 6
Filter your results:
Filter by:
-
IL-36G promotes cancer-cell intrinsic hallmarks in human gastric cancer cells
Authors: N Le, I Luk, D Chisanga, W Shi, L Pang, G Scholz, J Mariadason, M Ernst, J Huynh
Cytokine, 2022-05-02;155(0):155887.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Cathepsin G cleaves and activates IL-36? and promotes the inflammation of psoriasis
Authors: J Guo, J Tu, Y Hu, G Song, Z Yin
Drug Des Devel Ther, 2019-02-08;13(0):581-588.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.
Authors: Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J
Nature, 2012-07-26;487(7408):505-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
Authors: Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG
J. Invest. Dermatol., 2011-09-01;131(12):2428-37.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression.
Authors: Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, Ward NL, Wohn C, Prens EP, Wang F, Maier LE, Kang S, Voorhees JJ, Elder JT, Gudjonsson JE
J. Immunol., 2011-01-17;186(4):2613-22.
Applications: ELISA (Standard) -
S100A11, an dual mediator for growth regulation of human keratinocytes.
Authors: Sakaguchi M, Sonegawa H, Murata H, Kitazoe M, Futami J, Kataoka K, Yamada H, Huh NH
Mol. Biol. Cell, 2007-10-31;19(1):78-85.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human IL-36 gamma/IL-1F9 Protein
There are currently no reviews for this product. Be the first to review Recombinant Human IL-36 gamma/IL-1F9 Protein and earn rewards!
Have you used Recombinant Human IL-36 gamma/IL-1F9 Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image